SCHEDULE 13G/A: Institutional Investors Maintain Significant 9.83% Stake in Exagen Inc.
Beneficial Ownership Report
NMSIC Co-Investment Fund, L.P. and Sun Mountain Capital Partners, L.L.C. have reported a combined beneficial ownership of 9.83% in Exagen Inc., totaling 1,758,958 shares of common stock.
Summary
- This Schedule 13G/A (Amendment No. 6) filing reports the beneficial ownership of common stock in Exagen Inc. by NMSIC Co-Investment Fund, L.P. and its general partner, Sun Mountain Capital Partners, L.L.C.
- The reporting persons collectively beneficially own 1,758,958 shares of Exagen Inc. common stock.
- This ownership represents 9.83% of the outstanding common stock of Exagen Inc.
- The percentage is calculated based on 17,898,098 shares of common stock outstanding as of March 7, 2025, as reported in Exagen Inc.'s Annual Report on Form 10-K for the year ended December 31, 2024.
- Both NMSIC Co-Investment Fund, L.P. and Sun Mountain Capital Partners, L.L.C. hold sole voting and sole dispositive power over all 1,758,958 shares.
Sentiment
Score: 5
Explanation: Neutral filing reporting beneficial ownership, no direct positive or negative operational or financial news.
Positives
- The filing confirms a significant institutional stake (9.83%) in Exagen Inc. by NMSIC Co-Investment Fund, L.P. and Sun Mountain Capital Partners, L.L.C., which can be interpreted as a signal of continued investor confidence.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, potentially signaling investor confidence or a stable shareholder base.
Key Dates
| Date | Description |
|---|---|
| 2025-03-07 | Date as of which 17,898,098 shares of common stock were outstanding, used for beneficial ownership percentage calculation. |
| 2025-03-11 | Date Exagen Inc.'s Annual Report on Form 10-K for the year ended December 31, 2024, was filed with the SEC. |
| 2025-03-25 | Date of event which requires the filing of this statement. |
| 2025-04-17 | Signature date for Brian Birk and Lee Rand, Managing Members of Sun Mountain Capital Partners, L.L.C. |
Keywords
Exagen Inc., NMSIC Co-Investment Fund, Sun Mountain Capital, Schedule 13G, beneficial ownership, common stock, institutional investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.